{"name":"Methyldopa","slug":"methyldopa","kind":"substance","abbreviations":[],"systematic":null,"aliases":["αmethyldopa","Dopamet","Presolisin","Medomet","α medopa","l-α-Methyldopa","Methyldopa anhydrous","Aldometil","Methoplain","Sedometil"],"brands":[],"scraped":true,"has_structure":true,"cid":38853,"classes":[],"families":[{"name":"phentermine","href":"/substituted/phentermine"},{"name":"amino acid","href":"/substituted/amino_acid"}],"physical":[{"label":"Molecular mass","value":"211.21 g/mol","copyable":false},{"label":"Appearance","value":"Minute, anhyd crystals from methanol","copyable":false},{"label":"Odor","value":"ODORLESS","copyable":false},{"label":"Taste","value":"ALMOST TASTELESS","copyable":false},{"label":"Melting point","value":"572 °F approximately (decomposes) (NTP, 1992)","copyable":false},{"label":"Decomposition","value":"When heated to decomposition it emits toxic fumes of nitroxides.","copyable":false},{"label":"Solubility","value":"1 to 10 mg/mL at 73 °F (NTP, 1992)","copyable":false},{"label":"Predicted LogP","value":"-1.9","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>10</sub>H<sub>13</sub>NO<sub>4</sub>","copyable":true},{"label":"IUPAC name","value":"(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid","copyable":true},{"label":"SMILES","value":"C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N","copyable":true},{"label":"InChI","value":"InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1","copyable":true},{"label":"InChIKey","value":"CJCSPKMFHVPWAR-JTQLQIEISA-N","copyable":true},{"label":"CAS number","value":"555-30-6","copyable":true},{"label":"UNII","value":"M4R0H12F6M","copyable":true},{"label":"PubChem CID","value":"38853","copyable":true}],"pharmacokinetics":[{"label":"Onset","value":"4–6 hours","copyable":false},{"label":"Elimination half-life","value":"105 minutes","copyable":false},{"label":"Duration of action","value":"10–48 hours","copyable":false},{"label":"Metabolism","value":"Liver","copyable":false},{"label":"Excretion","value":"Kidney for metabolites","copyable":false},{"label":"Routes of administration","value":"By mouth, intravenous","copyable":false}],"toxicity":[{"kind":"LD50","organisms":[["Mouse",[{"kind":"LD50","organism":"Mouse","route":"ip","dose":"150 mg/kg"},{"kind":"LD50","organism":"Mouse","route":"iv","dose":"1700 mg/kg"}]],["Rat",[{"kind":"LD50","organism":"Rat","route":"oral","dose":"5000 mg/kg"},{"kind":"LD50","organism":"Rat","route":"ip","dose":"300 mg/kg"}]]]}],"dosing":null,"salts":[],"esters":[],"chirality":"absolute","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"C","description":"Cardiovascular system"},{"code":"C02","description":"Antihypertensives"},{"code":"C02A","description":"Antiadrenergic agents, centrally acting"},{"code":"C02AB","description":"Methyldopa"},{"code":"C02AB01","description":""},{"code":"C02AB01","description":"Methyldopa (levorotatory)"}],"mesh":[{"name":"Antihypertensive Agents","id":"M0001456"},{"name":"Sympatholytics","id":"M0020945"},{"name":"Adrenergic alpha-2 Receptor Agonists","id":"M0543921"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"ADRA2A","mechanisms":["shared target"],"partners":34,"contraindicated":12},{"target":"ADRA2B","mechanisms":["shared target"],"partners":32,"contraindicated":12},{"target":"ADRA2C","mechanisms":["shared target"],"partners":32,"contraindicated":12}],"mechanism":"The exact mechanism of methyldopa is not fully elucidated; however, the main mechanisms of methyldopa involve its actions on alpha-adrenergic receptor and the aromatic L-amino acid decarboxylase enzyme, to a lesser extent. The sympathetic outflow is regulated by alpha (α)-2 adrenergic receptors and imidazoline receptors expressed on adrenergic neurons within the rostral ventrolateral medulla. Methyldopa is metabolized to α‐methylnorepinephrine via dopamine beta-hydroxylase activity and, consequently, alpha-methylepinephrine via phenylethanolamine-N-methyltransferase activity. Mediating the therapeutic effects of methyldopa, α‐methylnorepinephrine and α-methylepinephrine active metabolites are agonists at presynaptic alpha-2 adrenergic receptors in the brainstem. Stimulating alpha-2 adrenergic receptors results in the inhibition of adrenergic neuronal outflow and attenuation of norepinephrine release in the brainstem. Consequently, the output of vasoconstrictor adrenergic signals to the peripheral sympathetic nervous system is reduced, leading to a reduction in blood pressure.  The L-isomer of alpha-methyldopa also reduces blood pressure by inhibiting aromatic L-amino acid decarboxylase, also known as DOPA decarboxylase, which is an enzyme responsible for the syntheses of dopamine and serotonin. Inhibiting this enzyme leads to depletion of biogenic amines such as norepinephrine. However, inhibition of aromatic L-amino acid decarboxylase plays a minimal role in the blood-pressure‐lowering effect of methyldopa.","side_effects":{"drug_id":4138,"drug_name":"methyldopa","url":"https://sideeffects.embl.de/drugs/4138/pt","atc_codes":["C02AB01","C02AB02"],"side_effects":[{"name":"Agranulocytosis","cui":"C0001824"},{"name":"Amenorrhoea","cui":"C0002453"},{"name":"Haemolytic anaemia","cui":"C0002878"},{"name":"Angina pectoris","cui":"C0002962"},{"name":"Arthralgia","cui":"C0003862"},{"name":"Musculoskeletal discomfort","cui":"C0948594"},{"name":"Myalgia","cui":"C0231528"},{"name":"Asthenia","cui":"C0004093"},{"name":"Mental disorder","cui":"C0004936"},{"name":"Breast disorder","cui":"C0006145"},{"name":"Colitis","cui":"C0009319"},{"name":"Infection","cui":"C0009450"},{"name":"Connective tissue disorder","cui":"C0009782"},{"name":"Constipation","cui":"C0009806"},{"name":"Libido decreased","cui":"C0011124"},{"name":"Disturbance in sexual arousal","cui":"C0855242"},{"name":"Diarrhoea","cui":"C0011991"},{"name":"Abdominal distension","cui":"C0000731"},{"name":"Dizziness","cui":"C0012833"},{"name":"Lightheadedness","cui":"C0220870"},{"name":"Eczema","cui":"C0013595"},{"name":"Oedema","cui":"C0013604"},{"name":"Endocrine disorder","cui":"C0014130"},{"name":"Eosinophilia","cui":"C0014457"},{"name":"Toxic epidermal necrolysis","cui":"C0014518"},{"name":"Dermatitis","cui":"C0011603"},{"name":"Rash","cui":"C0015230"},{"name":"Body temperature increased","cui":"C0015967"},{"name":"Flatulence","cui":"C0016204"},{"name":"Gastrointestinal disorder","cui":"C0017178"},{"name":"Gynaecomastia","cui":"C0018418"},{"name":"Headache","cui":"C0018681"},{"name":"Cardiac disorder","cui":"C0018799"},{"name":"Cardiac failure congestive","cui":"C0018802"},{"name":"Hepatitis","cui":"C0019158"},{"name":"Hyperprolactinaemia","cui":"C0020514"},{"name":"Hypersensitivity","cui":"C0020517"},{"name":"Orthostatic hypotension","cui":"C0020651"},{"name":"Jaundice","cui":"C0022346"},{"name":"Leukopenia","cui":"C0023530"},{"name":"Liver disorder","cui":"C0023895"},{"name":"Hepatocellular injury","cui":"C0151763"},{"name":"Foetor hepaticus","cui":"C0239571"},{"name":"Mediastinal disorder","cui":"C0025061"},{"name":"Myocarditis","cui":"C0027059"},{"name":"Nasal congestion","cui":"C0027424"},{"name":"Nausea","cui":"C0027497"},{"name":"Nervous system disorder","cui":"C0027765"},{"name":"Nightmare","cui":"C0028084"},{"name":"Pancreatitis","cui":"C0030305"},{"name":"Paraesthesia","cui":"C0030554"},{"name":"Pericarditis","cui":"C0031046"},{"name":"Psychotic disorder","cui":"C0033975"},{"name":"Sialoadenitis","cui":"C0037023"},{"name":"Thrombocytopenia","cui":"C0040034"},{"name":"Angiopathy","cui":"C0042373"},{"name":"Vasculitis","cui":"C0042384"},{"name":"Vomiting","cui":"C0042963"},{"name":"Weight increased","cui":"C0043094"},{"name":"Antinuclear antibody positive","cui":"C0151480"},{"name":"Liver injury","cui":"C0160390"},{"name":"Liver function test abnormal","cui":"C0151766"},{"name":"Pancytopenia","cui":"C0030312"},{"name":"Joint swelling","cui":"C0152031"},{"name":"Lichenoid keratosis","cui":"C1274594"},{"name":"Skin disorder","cui":"C0037274"},{"name":"Paradoxical pressor response","cui":"C0221733"},{"name":"Tenderness","cui":"C0234233"},{"name":"Coombs test positive","cui":"C0239113"},{"name":"Cerebrovascular insufficiency","cui":"C0241832"},{"name":"Erectile dysfunction","cui":"C0242350"},{"name":"Parkinsonism","cui":"C0242422"},{"name":"Hepatobiliary disease","cui":"C0267792"},{"name":"VIIth nerve paralysis","cui":"C0919980"},{"name":"Bradycardia","cui":"C0428977"},{"name":"Carotid sinus syndrome","cui":"C0221046"},{"name":"Infestation","cui":"C1384353"},{"name":"Lupus-like syndrome","cui":"C0919715"},{"name":"Breast enlargement","cui":"C2225524"}],"indications":[{"name":"Hypertension","cui":"C0020538"},{"name":"Hypertensive crisis","cui":"C0020546"}]},"effects":null,"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"Schedule 4","act":null,"refs":[]},{"jurisdiction":"Canada","status":"Prescription only","act":null,"refs":[]},{"jurisdiction":"United Kingdom","status":"Prescription only","act":null,"refs":[]},{"jurisdiction":"United States","status":"Prescription only","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Methyldopa"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/38853"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00968"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL459"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A61058"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=555-30-6"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0011754"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C07194"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID5023295"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Methyldopa"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/M4R0H12F6M"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/4138/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 38853, Methyldopa. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/38853>https://pubchem.ncbi.nlm.nih.gov/compound/38853</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Methyldopa. UNII: M4R0H12F6M. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/M4R0H12F6M>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/M4R0H12F6M</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 07:59:29","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 07:59:25","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 07:59:25","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 07:59:26","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 07:59:25","note":"hmdb.ca refused automated access to HMDB0011754"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 07:59:30","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 07:59:25","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 07:59:25","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 07:59:26","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 07:59:25","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 07:59:26","note":null}],"description":"Methyldopa is a  substance."}